-
1
Downregulation of the p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
2
Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”...
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
3
Decreasing systemic inflammation after TIPS: Still hope for the liver: Reply to correspondence on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained r...
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
4
The use of transient elastography for predicting hepatocellular carcinoma in chronic hepatitis B patients: Editorial on “Risk assessment of hepatitis B virus-related hepatocellular...
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
5
Correspondence to editorial on “Integrated molecular characterization of sarcomatoid hepatocellular carcinoma”
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
6
Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis...
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
7
Reply to correspondence on “Long-term gastrointestinal and hepatobiliary outcomes of COVID-19: A multinational population-based cohort study from South Korea, Japan, and the UK”...
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
8
Reply to correspondence on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
9
Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023
Published 2025-07-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
10
Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide coh...
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
11
Correspondence to editorial on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic revi...
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
12
Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
13
Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinom...
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
14
A complement to epigenetics in metabolic dysfunction-associated steatotic liver disease: Editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in a...
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
15
Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantati...
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
16
Reply to correspondence 1 on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
17
Liver organoids: Current advances and future applications for hepatology
Published 2025-02-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
18
Insights on risk score development: Considerations for early-stage hepatocellular carcinoma models
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
19
Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on “Aberrant fragmentomic features of circulating cell-free mitoc...
Published 2025-04-01“…Clinical and Molecular Hepatology…”
Get full text
Article -
20
Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screening
Published 2025-01-01“…Clinical and Molecular Hepatology…”
Get full text
Article